Cancer-derived exosomes trigger endothelial to mesenchymal transition followed by the induction of cancer-associated fibroblasts

Ju Hun Yeon, Hyo Eun Jeong, Hyemin Seo, Siwoo Cho, Kimin Kim, Dokyun Na, Seok Chung, Jaesung Park, Nakwon Choi, Ji Yoon Kang

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Cancer-associated fibroblasts (CAFs) play a pivotal role in tumor growth, but very little has been known about its characteristics and origin. Recently, cancer-derived exosome has been suggested to transdifferentiate CAFs, by a new mechanism of endothelial to mesenchymal transition (EndMT), initiating angiogenic processes and triggering metastatic evolution. However, an enabling tool in vitro is yet to be developed to investigate complicated procedures of the EndMT and the transdifferentiation under reconstituted tumor microenvironment. Here we proposed an in vitro microfluidic model which enables to monitor a synergetic effect of complex tumor microenvironment in situ, including extracellular matrix (ECM), interstitial flow and environmental exosomes. The number of CAFs differentiated from human umbilical vein endothelial cells (HUVECs) increased with melanoma-derived exosomes, presenting apparent morphological and molecular changes with pronounced motility. Mesenchymal stem cell (MSC)-derived exosomes were found to suppress EndMT, induce angiogenesis and maintain vascular homeostasis, while cancer-derived exosomes promoted EndMT. Capabilities of the new microfluidic model exist in precise regulation of the complex tumor microenvironment and therefore successful reconstitution of 3D microvasculature niches, enabling in situ investigation of EndMT procedure between various cell types. Statement of Significance: This study presents an in vitro 3D EndMT model to understand the progress of the CAF generation by recapitulating the 3D tumor microenvironment in a microfluidic device. Both cancer-derived exosomes and interstitial fluid flow synergetically played a pivotal role in the EndMT and consequent formation of CAFs through a collagen-based ECM. Our approach also enabled the demonstration of a homeostatic capability of MSC-derived exosomes, ultimately leading to the recovery of CAFs back to endothelial cells. The in vitro 3D EndMT model can serve as a powerful tool to validate exosomal components that could be further developed to anti-cancer drugs.

Original languageEnglish
JournalActa Biomaterialia
DOIs
Publication statusAccepted/In press - 2018 Jan 1

Fingerprint

Exosomes
Fibroblasts
Tumors
Tumor Microenvironment
Microfluidics
Neoplasms
Endothelial cells
Stem cells
Lab-On-A-Chip Devices
Mesenchymal Stromal Cells
Extracellular Matrix
Collagen
Extracellular Fluid
Human Umbilical Vein Endothelial Cells
Microvessels
Cancer-Associated Fibroblasts
Flow of fluids
Demonstrations
Blood Vessels
Melanoma

Keywords

  • Cancer-associated fibroblasts
  • Cancer-derived exosomes
  • Endothelial to mesenchymal transition
  • Interstitial flow
  • Microfluidic culture

ASJC Scopus subject areas

  • Biotechnology
  • Biomaterials
  • Biochemistry
  • Biomedical Engineering
  • Molecular Biology

Cite this

Cancer-derived exosomes trigger endothelial to mesenchymal transition followed by the induction of cancer-associated fibroblasts. / Yeon, Ju Hun; Jeong, Hyo Eun; Seo, Hyemin; Cho, Siwoo; Kim, Kimin; Na, Dokyun; Chung, Seok; Park, Jaesung; Choi, Nakwon; Kang, Ji Yoon.

In: Acta Biomaterialia, 01.01.2018.

Research output: Contribution to journalArticle

Yeon, Ju Hun ; Jeong, Hyo Eun ; Seo, Hyemin ; Cho, Siwoo ; Kim, Kimin ; Na, Dokyun ; Chung, Seok ; Park, Jaesung ; Choi, Nakwon ; Kang, Ji Yoon. / Cancer-derived exosomes trigger endothelial to mesenchymal transition followed by the induction of cancer-associated fibroblasts. In: Acta Biomaterialia. 2018.
@article{f1deabe4a1e64fbdb5d4a10bfe0b3a12,
title = "Cancer-derived exosomes trigger endothelial to mesenchymal transition followed by the induction of cancer-associated fibroblasts",
abstract = "Cancer-associated fibroblasts (CAFs) play a pivotal role in tumor growth, but very little has been known about its characteristics and origin. Recently, cancer-derived exosome has been suggested to transdifferentiate CAFs, by a new mechanism of endothelial to mesenchymal transition (EndMT), initiating angiogenic processes and triggering metastatic evolution. However, an enabling tool in vitro is yet to be developed to investigate complicated procedures of the EndMT and the transdifferentiation under reconstituted tumor microenvironment. Here we proposed an in vitro microfluidic model which enables to monitor a synergetic effect of complex tumor microenvironment in situ, including extracellular matrix (ECM), interstitial flow and environmental exosomes. The number of CAFs differentiated from human umbilical vein endothelial cells (HUVECs) increased with melanoma-derived exosomes, presenting apparent morphological and molecular changes with pronounced motility. Mesenchymal stem cell (MSC)-derived exosomes were found to suppress EndMT, induce angiogenesis and maintain vascular homeostasis, while cancer-derived exosomes promoted EndMT. Capabilities of the new microfluidic model exist in precise regulation of the complex tumor microenvironment and therefore successful reconstitution of 3D microvasculature niches, enabling in situ investigation of EndMT procedure between various cell types. Statement of Significance: This study presents an in vitro 3D EndMT model to understand the progress of the CAF generation by recapitulating the 3D tumor microenvironment in a microfluidic device. Both cancer-derived exosomes and interstitial fluid flow synergetically played a pivotal role in the EndMT and consequent formation of CAFs through a collagen-based ECM. Our approach also enabled the demonstration of a homeostatic capability of MSC-derived exosomes, ultimately leading to the recovery of CAFs back to endothelial cells. The in vitro 3D EndMT model can serve as a powerful tool to validate exosomal components that could be further developed to anti-cancer drugs.",
keywords = "Cancer-associated fibroblasts, Cancer-derived exosomes, Endothelial to mesenchymal transition, Interstitial flow, Microfluidic culture",
author = "Yeon, {Ju Hun} and Jeong, {Hyo Eun} and Hyemin Seo and Siwoo Cho and Kimin Kim and Dokyun Na and Seok Chung and Jaesung Park and Nakwon Choi and Kang, {Ji Yoon}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.actbio.2018.07.001",
language = "English",
journal = "Acta Biomaterialia",
issn = "1742-7061",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Cancer-derived exosomes trigger endothelial to mesenchymal transition followed by the induction of cancer-associated fibroblasts

AU - Yeon, Ju Hun

AU - Jeong, Hyo Eun

AU - Seo, Hyemin

AU - Cho, Siwoo

AU - Kim, Kimin

AU - Na, Dokyun

AU - Chung, Seok

AU - Park, Jaesung

AU - Choi, Nakwon

AU - Kang, Ji Yoon

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Cancer-associated fibroblasts (CAFs) play a pivotal role in tumor growth, but very little has been known about its characteristics and origin. Recently, cancer-derived exosome has been suggested to transdifferentiate CAFs, by a new mechanism of endothelial to mesenchymal transition (EndMT), initiating angiogenic processes and triggering metastatic evolution. However, an enabling tool in vitro is yet to be developed to investigate complicated procedures of the EndMT and the transdifferentiation under reconstituted tumor microenvironment. Here we proposed an in vitro microfluidic model which enables to monitor a synergetic effect of complex tumor microenvironment in situ, including extracellular matrix (ECM), interstitial flow and environmental exosomes. The number of CAFs differentiated from human umbilical vein endothelial cells (HUVECs) increased with melanoma-derived exosomes, presenting apparent morphological and molecular changes with pronounced motility. Mesenchymal stem cell (MSC)-derived exosomes were found to suppress EndMT, induce angiogenesis and maintain vascular homeostasis, while cancer-derived exosomes promoted EndMT. Capabilities of the new microfluidic model exist in precise regulation of the complex tumor microenvironment and therefore successful reconstitution of 3D microvasculature niches, enabling in situ investigation of EndMT procedure between various cell types. Statement of Significance: This study presents an in vitro 3D EndMT model to understand the progress of the CAF generation by recapitulating the 3D tumor microenvironment in a microfluidic device. Both cancer-derived exosomes and interstitial fluid flow synergetically played a pivotal role in the EndMT and consequent formation of CAFs through a collagen-based ECM. Our approach also enabled the demonstration of a homeostatic capability of MSC-derived exosomes, ultimately leading to the recovery of CAFs back to endothelial cells. The in vitro 3D EndMT model can serve as a powerful tool to validate exosomal components that could be further developed to anti-cancer drugs.

AB - Cancer-associated fibroblasts (CAFs) play a pivotal role in tumor growth, but very little has been known about its characteristics and origin. Recently, cancer-derived exosome has been suggested to transdifferentiate CAFs, by a new mechanism of endothelial to mesenchymal transition (EndMT), initiating angiogenic processes and triggering metastatic evolution. However, an enabling tool in vitro is yet to be developed to investigate complicated procedures of the EndMT and the transdifferentiation under reconstituted tumor microenvironment. Here we proposed an in vitro microfluidic model which enables to monitor a synergetic effect of complex tumor microenvironment in situ, including extracellular matrix (ECM), interstitial flow and environmental exosomes. The number of CAFs differentiated from human umbilical vein endothelial cells (HUVECs) increased with melanoma-derived exosomes, presenting apparent morphological and molecular changes with pronounced motility. Mesenchymal stem cell (MSC)-derived exosomes were found to suppress EndMT, induce angiogenesis and maintain vascular homeostasis, while cancer-derived exosomes promoted EndMT. Capabilities of the new microfluidic model exist in precise regulation of the complex tumor microenvironment and therefore successful reconstitution of 3D microvasculature niches, enabling in situ investigation of EndMT procedure between various cell types. Statement of Significance: This study presents an in vitro 3D EndMT model to understand the progress of the CAF generation by recapitulating the 3D tumor microenvironment in a microfluidic device. Both cancer-derived exosomes and interstitial fluid flow synergetically played a pivotal role in the EndMT and consequent formation of CAFs through a collagen-based ECM. Our approach also enabled the demonstration of a homeostatic capability of MSC-derived exosomes, ultimately leading to the recovery of CAFs back to endothelial cells. The in vitro 3D EndMT model can serve as a powerful tool to validate exosomal components that could be further developed to anti-cancer drugs.

KW - Cancer-associated fibroblasts

KW - Cancer-derived exosomes

KW - Endothelial to mesenchymal transition

KW - Interstitial flow

KW - Microfluidic culture

UR - http://www.scopus.com/inward/record.url?scp=85049579473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049579473&partnerID=8YFLogxK

U2 - 10.1016/j.actbio.2018.07.001

DO - 10.1016/j.actbio.2018.07.001

M3 - Article

C2 - 30078422

AN - SCOPUS:85049579473

JO - Acta Biomaterialia

JF - Acta Biomaterialia

SN - 1742-7061

ER -